GETNE Registration of Thyroid Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Thyroid Cancer. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Spain
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Descriptive Observational Epidemiological Study on the Characteristics of Thyroid Cancer in Patients Treated in Oncology Services of Spanish Centers: National Registry of Thyroid Cancer - Differentiated, Medullary and Anaplastic
Overview
An epidemiological, observational, multicenter, cross-sectional, retrospective study on patients ≥ 18 years visited in the oncology services of the participating centers with diagnosis of primary thyroid cancer.
Primary outcome measures
- Hystopathological characteristics of the tumor [Time frame: Baseline]
- Situation of the tumor at first-diagnosis [Time frame: Baseline]
- Tumor-Node-Metastasis classification [Time frame: Baseline]
- Tumor Stage [Time frame: Baseline]
Secondary outcome measures (8)
- Patient situation at the end of treatment [Time frame: 12 months]
- Number of patients with BRAF mutation [Time frame: 12 months]
- Number of patients with RET mutation [Time frame: 12 months]
- Number of patients with PI3K mutation [Time frame: 12 months]
- Number of patients with RAS mutation [Time frame: 12 months]
- Number of patients with PAX8/PAR mutation [Time frame: 12 months]
- Number of patients with P53 mutation [Time frame: 12 months]
- Number of patients with PTEN mutation [Time frame: 12 months]
Eligibility criteria
Inclusion criteria
- Patients older than 18 years with diagnosis of differentiated, medullary or anaplastic thyroid cancer confirmed by histopathology.
- Patients who agree to participate and are able to understand the information sheet and sign the informed consent
Exclusion criteria
- Patients under 18 years of age.
- Patients with other types of thyroid cancer or whose histopathological diagnosis has not been confirmed.
- Patients who do not have the relevant basic information to be included in the study, according to the criteria of the principal investigator.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Ecologic or community
Study locations
Spain · 1 center
- Hospital Universitari Vall d'Hebron — Barcelona
Identifiers
NCT: NCT03765333 · REGETNE-Tiroides